A practical guide to venture debt warrants — what they are, how they work, their impact on dilution, and how founders can negotiate the best terms.

Updated October 13, 2026

Key takeaways

  • Venture debt warrants give the lender the right — but not the obligation — to purchase shares at a set price within a set timeframe, compensating the lender for the risk of lending to an unprofitable, high-growth startup.
  • Warrant coverage and dilution are different numbers. Coverage is a percentage of the loan amount; dilution is the percentage of ownership the lender ends up with. Conflating them is one of the most common founder mistakes.
  • Typical coverage runs 5–50 bps (0.05%–0.5%) of fully diluted shares, or 2–10% of the loan amount (up to 15–30% for higher-risk deals). The resulting dilution is usually just 0.5–2%.
  • Venture debt warrants are almost always exercised on a cashless basis upon a liquidation event such as an M&A or IPO — the lender never pays cash out of pocket.
  • Coverage percentage, strike price, expiration date, and buyback rights are all negotiable, especially when you have multiple term sheets or a recent equity close. Understanding these warrant terms is the key to minimizing warrant dilution.

Venture debt is often marketed as “non-dilutive capital,” a way to extend runway without giving up equity. That framing is mostly true, but it hides a real cost: the venture debt warrant. Embedded in most venture debt term sheets, a warrant represents a small but genuine future equity stake for the lender. Founders who understand how venture debt warrants work (how coverage is calculated, how exercise mechanics function, and what’s negotiable) can make better financing decisions and accurately compare venture debt to an equity round.

What is a venture debt warrant?

In startup finance, a warrant is a contract that gives the holder the right — but not the obligation — to purchase a specific number of shares of a company at a set price (the strike price) within an established timeframe. The warrant doesn’t immediately grant shares, but grants the right to buy them. In the context of venture debt, the lender is the warrant holder and the startup is the issuer.

“A warrant is essentially the lender’s upside participation in your company’s success,” explains Thomas Bird, Associate Director, Credit Advisory at RBCx. “It compensates the lender for taking on the risk of lending to a company that may not yet be profitable. The key thing for founders to understand is that it’s a right, not an obligation, so the lender only benefits if the company does well.”

Four core components define how a venture debt warrant works:

  • Warrant coverage — the number of shares the warrant covers, typically expressed as a percentage of the loan amount or of fully diluted shares
  • Strike (exercise) price — the price per share at which the lender can purchase shares
  • Expiration date — the window during which the warrant can be exercised
  • Type of stock — usually common shares, though some warrants cover preferred shares

Why warrants are issued in venture debt

Warrants exist in venture debt to compensate the lender for risk. It starts with covenants: when banks write traditional term loans, they typically attach financial covenants that govern the borrower’s cash flow levels. But startups are cash-burning by nature, so those cash flow covenants don’t work. In their place, warrants tie the lender’s interests to the borrower’s growth. The lender stays focused on getting repaid and remains at the top of the capital stack, but now has a vested interest in the company’s success — without burdening the company with a leverage or cash-flow-based covenant.

Why warrants instead of just issuing shares? First, issuing new shares usually only happens during a live equity round, and founders are rightly protective of the capitalization table (cap table). Warrants are an agreement, not shares, so they sit beside the cap table, not on it. Second, lenders aren’t equity investors; regulated institutions are limited in how much equity they can hold and must reserve more risk capital against shares than loans. Warrants require no such risk capital.

From the lender’s portfolio perspective, warrants follow the same power law as venture capital: most gains come from a few home runs. As a portfolio grows, warrant positions offset losses across the debt book, which is what allows lenders to keep lending in the venture debt market. Warrant coverage also scales with risk: a seed-stage company will typically face higher coverage than a Series D company, reflecting its earlier stage and higher-risk profile.

How venture debt warrants work

This is the core of what founders need to understand. When a startup takes on venture debt, the lender typically requires a warrant as part of the deal. The warrant coverage in venture debt (the amount of equity the warrant represents) is negotiated and documented in the warrant agreement.

Warrants range in venture debt based on the lender’s risk assessment:

  • As a percentage of fully diluted shares: 5–50 basis points (0.05%–0.5%)
  • As a percentage of the loan amount: 2–10% for standard deals, up to 15–30% for higher-risk or earlier-stage companies
  • Resulting dilution to founders: typically 0.5–2%

“The coverage percentage is the single most important number in the warrant clause, and it’s also the one founders most often misunderstand,” says Bird. “A 10% coverage rate doesn’t mean you’re giving up 10% of your company — it means the lender can purchase shares worth 10% of the loan amount. The actual warrant dilution ends up being a fraction of that, because the lender still has to pay the strike price.”

Warrants vs. options

It’s worth clarifying the difference between warrants and options, since the terms are sometimes used interchangeably. Options are typically issued to employees, advisors, and board members as part of compensation and incentive plans. Warrants are typically issued to lenders and investors as part of a financing transaction. The mechanics are similar — both give the holder the right to purchase shares at a set price within a set timeframe — but the context and purpose differ. The warrant terms are negotiated separately from any employee pool option, and they’re governed by their own agreement rather than the company’s option plan. In venture debt, you’re dealing with warrants, not options.

Key terms in a warrant agreement

The four components above define what a warrant is. Warrant agreements are the legal document that governs them — they include several additional provisions that affect how and when the lender can exercise. These are the warrant terms founders should look for when reading a warrant clause in a venture debt term sheet:

  • Allocation — how the warrant shares are allocated and calculated
  • Fully diluted shares — the total share count used to calculate the warrant, including all convertible securities and options
  • Cashless exercise provision — allows the lender to exercise without paying cash out of pocket. Warrant exercise in venture debt is almost always cashless (see below)
  • Put option — some lenders include a put option giving them the right to sell the warrant back to the startup after a set period
  • Coverage vs. dilution — don’t confuse these. Warrant coverage is the percentage of the loan amount the lender can buy shares for; dilution is the percentage of company ownership the lender ends up with. These are different numbers, and coverage is always larger than the resulting dilution. Dilution from warrants is typically a fraction of what an equity round would cost.

How venture debt warrants are exercised

Warrant exercise only happens when the current market value of a company’s shares is higher than the strike price — otherwise, there’s no financial reason to exercise. For venture debt warrants, exercise typically happens upon a liquidation event: a merger, acquisition, or initial public offering (IPO).

Cashless exercise is the standard mechanism for venture debt warrants. In a cashless exercise, the lender doesn’t pay cash to purchase the shares. Instead, the purchase cost is deducted from the capital gain. The lender receives the net value of the shares minus the strike price cost, without putting up any capital. Venture debt warrants are almost always exercised on a cashless basis.

“Because venture debt warrants are almost always cashless, the lender never has to write a cheque to exercise,” notes Bird. “When a liquidation event happens, the warrant is automatically exercised and the lender receives the net value. Founders should understand this — it means the warrant will essentially always be exercised if there’s a successful exit, so the dilution is real, even if small.”

M&A vs. IPO: In a private merger or acquisition (M&A), the lender typically receives a cashless payment from the acquirer — the share price less the strike — without ever holding the shares. In an initial public offering (IPO), once the lock-up period ends the lender exercises the warrant, receives the shares, and sells them. If the acquirer pays in stock, the warrant becomes exercisable on the acquirer’s stock until expiration. In all cases, the warrant holder is entitled to their share of proceeds, which must be accounted for during exit negotiations.

When there’s no exit: A company that continues operating without a liquidation event presents a middle ground. A venture debt warrant might have a maturity of up to 12 years. If that period passes with no acquisition, no IPO, and the company’s value has declined, the warrant carries no value and expires unexercised.

Worked example: a venture debt warrant from issuance to exercise

The following example illustrates how a venture debt warrant works from issuance through exercise. Company XYZ has just raised an equity round and is seeking venture debt. A year later, the company is acquired — let’s walk through what happens to the warrant.

Step Event Details
1 Company XYZ raises venture debt $8 million loan; the lender requests 25 bps of warrant allocation
2 Warrant is issued Company XYZ has 5,000,000 fully diluted shares; the warrant covers 12,500 shares (5,000,000 × 0.25% = 12,500)
3 Strike price is set $12 per share — the fair market value at issuance, based on the most recent equity round
4 One year later: acquisition Company XYZ is acquired for $100 million; the share price has increased from $12 to $20 per share
5 Warrant is exercised (cashless) The lender exercises the warrant on a cashless basis upon the liquidation event
6 Value to lender 12,500 shares × $20 = $250,000 proceeds; minus strike cost of 12,500 × $12 = $150,000; net gain to lender = $100,000
7 Dilution to founders 12,500 shares ÷ 5,000,000 fully diluted shares = 0.25% ownership transferred to the lender

Key takeaway: Dilution from warrants is typically just 0.5-2% — a fraction of the 15–25% dilution a typical equity round would cost. In this example, the lender’s warrant coverage was 25 bps (0.25% of fully diluted shares), resulting in just 0.25% dilution to founders. This is why venture debt with warrants is often described as “less dilutive” than equity, even though it isn’t strictly non-dilutive.

What can founders negotiate?

The warrant isn’t a take-it-or-leave-it term. Several elements are negotiable, and founders who come prepared can meaningfully reduce their dilution exposure by negotiating favourable warrant terms:

  • Warrant coverage percentage — This is the most impactful lever. Push for lower coverage, especially if you have multiple term sheets or a recent equity close that reduces the lender’s perceived risk.
  • Strike price — Usually set at fair market value at issuance, but sometimes negotiable to a discount. A lower strike price benefits the lender, not the founder, so you generally want the strike set at current fair market value.
  • Expiration date — Shorter terms reduce the lender’s upside window. A shorter expiry means the warrant is less valuable to the lender, which can be a trade-off for other terms.
  • Buyback / cancellation rights — Some lenders will agree to cancel unexercised warrants after the loan is repaid or after a set period. This can eliminate the dilution risk entirely if your company doesn’t have a liquidation event within the window.
  • Put options — Be aware if the lender requires a put option, which gives them the right to sell the warrant back to the startup after a set period. Understand the terms and timing before signing.

“The founders who get the best warrant terms are the ones who treat it as a negotiation, not a given,” says Bird. “If you have two or three term sheets, or you’ve just closed an equity round, you have leverage. Use it. Even a small reduction in coverage percentage compounds over the life of the company.”

Understanding the cost of venture debt warrants

The venture debt cost of warrant coverage is real but typically small cost to founders. The resulting warrant dilution — usually 0.5–2% — is a fraction of what an equity round would cost (often 15–25% or more). For founders weighing venture debt against equity, the warrant is the key variable that determines the true cost of the “non-dilutive” capital.

The fact that a warrant is exercised only when there’s a successful exit is itself a signal: if your lender exercises their warrant, it means your company has grown significantly in value. The dilution is real, but it comes packaged with success.

“Venture debt with warrants is one of the most founder-friendly financing tools available, when you understand the economics,” says Bird. “The dilution is small, it only happens on a successful exit, and the terms are negotiable. The founders who get into trouble are the ones who don’t read the warrant clause carefully and are surprised at exit. Read the clause, understand your coverage, and negotiate.”

If you’re considering venture debt for your startup, RBCx offers credit advisory services to help you evaluate term sheets, understand warrant clauses, and structure financing that supports your growth. Speak with an RBCx Advisor to learn more.

FAQs

A warrant gives a venture debt lender the right (not obligation) to purchase shares at a set price within a set timeframe, compensating the lender for the risk of lending to an unprofitable, high-growth startup.

Dilution from warrants is typically 0.5% to 2% ownership dilution. The warrant coverage (a percentage of the loan, often 2–10%) translates to a much smaller warrant dilution outcome because the lender must still pay the strike price.

Coverage is the percentage of the loan amount the lender can buy shares for; dilution is the percentage of company ownership the lender ends up with. They are different numbers — coverage is always larger than the resulting dilution.

Yes. Coverage percentage, strike price, expiration date, and buyback rights are all negotiable, especially when you have multiple term sheets, strong financials, or a recent equity close that reduces perceived risk. Understanding the full set of warrant terms is the key to minimizing dilution.

Warrants are typically exercised upon a liquidation event such as an M&A or IPO. If acquired, the warrant may convert to the acquirer’s stock or be cashed out at the acquisition price. This should be accounted for during M&A negotiations.

In a cashless exercise, the lender doesn’t pay cash for the shares; instead, the cost to purchase the shares is deducted from the capital gain. Warrant exercise in venture debt is almost always cashless — the lender never pays out of pocket.

No. Some established lenders offer non-dilutive venture debt without warrants, accepting lower returns for lower risk. Warrant requirements depend on the lender’s risk model and the startup’s stage and financial profile.

Warrant pricing in venture debt is determined by two factors: the strike price and the coverage amount. The strike price is typically set at the fair market value of the shares at the time the warrant is granted, based on the most recent financing round. The coverage amount is expressed as a percentage of the company’s fully diluted shares (commonly 5–50 bps) or as a percentage of the loan.

This article is intended as general information only and is not to be relied upon as constituting legal, financial or other professional advice. The reader is solely liable for any use of the information contained in this document and Royal Bank of Canada (“RBC”) nor any of its affiliates nor any of their respective directors, officers, employees or agents shall be held responsible for any direct or indirect damages arising from the use of this document by the reader. A professional advisor should be consulted regarding your specific situation. Information presented is believed to be factual and up-to-date but we do not guarantee its accuracy and it should not be regarded as a complete analysis of the subjects discussed. All expressions of opinion reflect the judgment of the authors as of the date of publication and are subject to change. No endorsement of any third parties or their advice, opinions, information, products or services is expressly given or implied by Royal Bank of Canada or any of its affiliates.

RELATED TOPICS

Other articles you may be interested in